Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × olaparib × Clear all

NCT03834519 2025-05-18

KEYLYNK-010

Phase 3 Completed

793 enrolled 23 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms